Skip to main content

Animations

MJFF Publications

1121 - 1130 of 8620 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    RESTRICTED
    Title: Quantitative determination of LY‐404,039, a metabotropic glutamate 2/3 receptor agonist, in rat plasma using chemical derivatization and HPLC–MRM/MS
    Journal Name: Biomedical Chromatography
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/bmc.5423
    Best OA location URL:
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Application of longitudinal item response theory models to modeling Parkinson’s disease progression
    Journal Name: CPT: Pharmacometrics & Systems Pharmacology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/psp4.12853
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Long‐term independence and quality of life after subthalamic stimulation in Parkinson disease
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1111/ene.15436
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Pre‐existing humoral immune comebacks control the development of the severe form of coronavirus disease 2019 in Gaucher patients
    Journal Name: Clinical and Translational Discovery
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/ctd2.96
    Citation Count: 6
  • Summary Details
    RESTRICTED
    Title: A novel risk calculator predicting surgical site infection after spinal surgery in patients with cerebral palsy
    Journal Name: Developmental Medicine & Child Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/dmcn.15193
    Best OA location URL:
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Clinical autonomic nervous system laboratories in Europe
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1111/ene.15538
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Neurological outcomes 1 year after COVID‐19 diagnosis: A prospective longitudinal cohort study
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/ene.15307
    Citation Count: 97
  • Summary Details
    OPEN
    Title: Concerns about the European Academy's Recommendations and Guidelines Regarding Pallidotomy for Parkinson's Disease
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/ene.15569
    Citation Count: 4
  • Summary Details
    OPEN
    Title: European Academy of Neurology/Movement Disorder Society ‐ European Section guideline on the treatment of Parkinson's disease: I. Invasive therapies
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1111/ene.15386
    Citation Count: 54
  • Summary Details
    OPEN
    Title: Description of a European memory clinic cohort undergoing amyloid‐PET: The AMYPAD Diagnostic and Patient Management Study
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/alz.12696
    Citation Count: 12
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.